Torsades de pointes associated with fluoroquinolones

被引：74

作者：

Owens, RC

Ambrose, PG

机构：

[1] Maine Med Ctr, Dept Clin Pharm, Portland, ME 04102 USA

[2] Maine Med Ctr, Dept Infect Dis, Portland, ME 04102 USA

[3] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA

[4] Cognigen Corp, Buffalo, NY USA

[5] Univ Pacific, Sch Hlth Sci, Stockton, CA 95211 USA

来源：

PHARMACOTHERAPY | 2002年 / 22卷 / 05期

关键词：

D O I：

10.1592/phco.22.8.663.33201

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：663 / 668

页数：6

共 30 条

[1] Seasonal variation in fluoroquinolone prescribing [J].

Abell, S ;

Chapman, S ;

Nadin, L ;

Warren, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) :315-316

[2]

Anderson ME, 2001, J PHARMACOL EXP THER, V296, P806

[3] The safety profile of the fluoroquinolones [J].

Bertino, J ;

Fish, D .

CLINICAL THERAPEUTICS, 2000, 22 (07) :798-817

[4] Gatifloxacin-associated corrected QT interval prolongation, Torsades de pointes, and ventricular fibrillation in patients with known risk factors [J].

Bertino, JS ;

Owens, RC ;

Carnes, TD ;

Iannini, PB .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :861-863

[5] Effects of fluoroquinolones on HERG currents [J].

Bischoff, U ;

Schmidt, C ;

Netzer, R ;

Pongs, O .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (03) :341-343

[6] Postmarketing surveillance and adverse drug reactions - Current perspectives and future needs [J].

Brewer, T ;

Colditz, GA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (09) :824-829

[7] The pre-clinical assessment of QT interval prolongation:: a comparison of in vitro and in vivo methods [J].

Davis, AS .

HUMAN & EXPERIMENTAL TOXICOLOGY, 1998, 17 (12) :677-680

[8] Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs:: A call for consensus [J].

De Ponti, F ;

Poluzzi, E ;

Montanaro, N .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (03) :185-209

[9] Rates of Torsades de Pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin [J].

Frothingham, R .

PHARMACOTHERAPY, 2001, 21 (12) :1468-1472

[10]

GRIFFIN JP, 1985, ADVERSE DRUG REACT T, V4, P213

← 1 2 3 →